Dr Melvin Chin is a medical oncologist at Sir Charles Gairdner hospital. He came to Perth after completing his medical degree at the University of Cambridge in 2011. He has a strong research interest in mesothelioma and has explored computational approaches to discover cancer biomarkers from mesothelioma gene expression data.
He is a past recipient of the ADSA (Asbestos Diseases Society of Australia) PhD scholarship and a current recipient of a Raine Clinician Research Fellowship. Currently, his research focuses on machine learning approaches to predict mesothelioma responses to chemotherapy and immunotherapy treatment.